Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2527445 | Clinical Therapeutics | 2012 | 18 Pages |
Abstract
These 10-week data from this patient population suggest a greater antihypertensive efficacy of the fixed-dose combination I300/A5 over I300 alone in lowering systolic blood pressure. Both treatments were well tolerated throughout the study. ClinicalTrials.gov identifier: NCT00957554.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Guillaume MD, I-ADD Study Investigators I-ADD Study Investigators,